Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Bio-Rad Laboratories in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a NaN upside from the last price of $0.00.
Current Consensus is
The current consensus among 0 investment analysts is to n/a stock in Bio-Rad Laboratories. This rating has held steady since December 2020, when it changed from a Buy consensus rating.